The Current Ratio as of September 2024 (TTM) for Coya Therapeutics, Inc. (COYA) is 10.43

According to Coya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.43. This represents a change of 23.51% compared to the average of 8.44 of the last 4 quarters.

Coya Therapeutics, Inc. (COYA) Historical Current Ratio (quarterly & annually)

How has COYA Current Ratio performed in the past?

The mean historical Current Ratio of Coya Therapeutics, Inc. over the last ten years is 8.40. The current 10.43 Current Ratio has changed 12.32% with respect to the historical average. Over the past ten years (40 quarters), COYA's Current Ratio was at its highest in in the March 2023 quarter at 13.69. The Current Ratio was at its lowest in in the March 2021 quarter at 0.

Coya Therapeutics, Inc. (COYA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Coya Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Coya Therapeutics, Inc. (COYA) Average Current Ratio

How has COYA Current Ratio performed in the past?

The current Current Ratio of Coya Therapeutics, Inc. (COYA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Coya Therapeutics, Inc. (COYA) Current Ratio vs. Peers

How is COYA’s Current Ratio compared to its peers?

Coya Therapeutics, Inc.’s Current Ratio is greater than Cue Biopharma, Inc. (2.06), greater than Lantern Pharma Inc. (7.67), greater than Fennec Pharmaceuticals Inc. (8.02), less than Eliem Therapeutics, Inc. (60.41), less than Acumen Pharmaceuticals, Inc. (17.37), greater than Inozyme Pharma, Inc. (9.84), less than Terns Pharmaceuticals, Inc. (21.02), greater than Day One Biopharmaceuticals, Inc. (4.09), greater than Galera Therapeutics, Inc. (5.63), greater than Cognition Therapeutics, Inc. (3.07), greater than TFF Pharmaceuticals, Inc. (1.63), greater than TScan Therapeutics, Inc. (7.77), greater than Dermata Therapeutics, Inc. (2.73), greater than NewAmsterdam Pharma Company N.V. (9.83), less than Centessa Pharmaceuticals plc (13.29), greater than Sutro Biopharma, Inc. (3.41), greater than Opthea Limited (2.94), greater than HilleVax, Inc. (5.14), greater than Gain Therapeutics, Inc. (2.84), greater than aTyr Pharma, Inc. (6.07), greater than IN8bio, Inc. (2.66),

Build a custom stock screener for Coya Therapeutics, Inc. (COYA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Coya Therapeutics, Inc. (COYA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Coya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.